R. Lin

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?

J. McDonald, M. Schoeman, R. Batey, 1991, Australian and New Zealand journal of medicine.

Hepatitis C as the cause of chronic non‐A, non‐B hepatitis: High sensitivity of simultaneous measurement of core and non‐structural antibodies

M. Yano, G. Farrell, R. Lin, 1992, Journal of gastroenterology and hepatology.

Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C

K. Byth, C. Liddle, R. Lin, 1996, Journal of viral hepatitis.

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates: Results of the first multicentre Australian trial

S. Strasser, R. Lin, M. Zimmerman, 1995 .

Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study.

J. Kench, K. Byth, M. Weltman, 1999, Australian and New Zealand journal of medicine.

Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

J. Kench, K. Byth, G. Farrell, 1998, Human pathology.